Detail page

Knowledge Web

Person

Maria-Luisa Schubert (1982-)

Ärztin

Name	Maria-Luisa Schubert
Time	1982- (Date of birth and death)
Place	Heidelberg (Wirkungsort) Deutschland
Academic degree	Dr. med. (Univ. Heidelberg) (2017)
Profession	Ärztin (characteristic profession)
Variant	Luisa Schubert
Related	Klinikum Heidelberg Biotechnologie (Molekulare Biotechnologie) (Studienfach)
Further information	Assistenzärztin Medizinische Klinik Heidelberg, Hämatologie, Onkologie, Rheumatologie, Universitätsklinikum Heidelberg
Record type	Person
GND-Identifier	1147867631
Record ID	1147867631
Involved in show all Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial Outcomes of axicabtagene ciloleucel in PMBCL compare favorably to DLBCL: a GLA/DRST registry study Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Maria-Luisa Schubert (1982-)

Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably to DLBCL: a GLA/DRST registry study

Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial

Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data

Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells

Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies

Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression